Stimulant Use Disorder: Clinical Trials

4 trials for Stimulant Use Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 not yet recruiting. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Completed 1, Not yet recruiting 1

Follow Stimulant Use Disorder: new trials by email Literature Review of Stimulant Use Disorder trials Research Report on Stimulant Use Disorder

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study
PEX010-Assisted Therapy, PEX010(01) - Stimulant Use Disorder
Phase 2Not yet recruitingFilament Health Corp.862025-01-012024-10-30
Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder
SUVO, TAU - Stimulant Use Disorder
Phase 2RecruitingThe University of Texas Health Science Center, Houston202024-07-252025-09-05
Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment
Mirtazapine, Placebo - Stimulant Use Disorder
Phase 2RecruitingWashington State University602024-06-172026-07-02
Suvorexant for Opioid/Stimulant Co-use
Suvorexant (dual orexin receptor antagonist), Placebo - Opioid Use Disorder, Stimulant Use Disorder
Phase 2CompletedJohns Hopkins University202022-12-012025-12-23

Narrower conditions

Substance-Related Disorders (2)  ·  Chemically-Induced Disorders (1)  ·  Narcotic-Related Disorders (1)  ·  Opioid-Related Disorders (1)

Broader conditions

Mental Disorders (2)  ·  Chemically-Induced Disorders (1)

Interventions

Mirtazapine (1)  ·  Orexin Receptor Antagonists (1)  ·  suvorexant (1)

Sponsors

Filament Health Corp. (1)  ·  Johns Hopkins University (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Washington State University (1)

Countries

United States (3)

Top investigators

Heather Webber, PhD (1)  ·  Jennifer Ellis, Ph.D. (1)  ·  Sterling M McPherson, PhD (1)

Results publications

PMID 41950275